Skip to main content
Clinical Trials/NCT06697145
NCT06697145
Completed
Not Applicable

Assessment of the Durability and Clinical Effectiveness of Parasympathetic Denervation Following Cardioneuroablation Using Physiological Indices of Heart Rate Reactivity

Wroclaw Medical University1 site in 1 country12 target enrollmentNovember 23, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Syncope, Vasovagal, Neurally-Mediated
Sponsor
Wroclaw Medical University
Enrollment
12
Locations
1
Primary Endpoint
Change in degree of parasympathetic denervation (%)
Status
Completed
Last Updated
last year

Overview

Brief Summary

Cardioneuroablation is a novel treatment option for reflex-mediated syncope. It involves thermal destruction of neural tissue in the close proximity of heart using catheter introduced to the heart through vein in the groin. Effectiveness of the procedure is satisfactory, however, in some cases there is a possibility of the re-growth of previously ablated tissue. We aim to investigate whether this process could be traced by measurement of various physiological parameters related to heart rate reactivity. Additionally we intend to reveal whether changes in those parameters over time could influence clinical effeciveness of the procedure.

Registry
clinicaltrials.gov
Start Date
November 23, 2021
End Date
December 31, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Wroclaw Medical University
Responsible Party
Principal Investigator
Principal Investigator

Piotr Niewinski, MD

MD, PhD

Wroclaw Medical University

Eligibility Criteria

Inclusion Criteria

  • signed informed consent
  • sinus rhythm
  • clinical indications for cardioneuroablation for the treatment of vagally-mediated syncope

Exclusion Criteria

  • pregnancy
  • known atropine hypersensitivity

Outcomes

Primary Outcomes

Change in degree of parasympathetic denervation (%)

Time Frame: 12 months

Secondary Outcomes

  • Change in heart rate (beats/min)(12 months)
  • Change in heart rate variability (ms)(12 months)
  • Change in cardiac barosensitivity (ms/mmHg)(12 months)
  • Change in hypoxic heart rate response (beats/min SpO2)(12 months)
  • Time to recurrence of syncopal event (days(12 months)

Study Sites (1)

Loading locations...

Similar Trials